Phase II trial of gemcitabine in patients with advanced gastric cancer Academic Article Article uri icon

Overview

MeSH Major

  • Mycosis Fungoides
  • Sezary Syndrome

abstract

  • Gemcitabine at this dose and schedule has no significant antitumor activity in gastric cancer.

publication date

  • January 1994

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19940101)73:1<5::AID-CNCR2820730103>3.0.CO;2-#

PubMed ID

  • 8275437

Additional Document Info

start page

  • 5

end page

  • 7

volume

  • 73

number

  • 1